The Essential Role of Pharmaceutical Companies in STI Clinical Trials
Sexually transmitted infections (STI) represent a significant public health challenge, non-discriminatory of age, gender, or sexual orientation. The alarming rate of STI incidence, especially diseases like chlamydia, gonorrhea, syphilis, HIV/AIDS, etc., is currently boosted by the unprecedented fast-paced dynamics of modern societies. As some STIs may remain asymptomatic for years, underlining the urgency for early […]
